We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MERIDIAN BIOSCIENCE

Meridian Bioscience manufactures, markets, and distributes diagnostic test kits, purified reagents and biopharmaceuti... read more Featured Products: More products

Download Mobile App





Meridian Showcases Innovative Solutions for Molecular Diagnostics and Immunoassays

By LabMedica International staff writers
Posted on 11 Nov 2024
Print article
Image: Meridian is presenting its innovative solutions in molecular and immunoassay reagents at MEDICA 2024 (Photo courtesy of Meridian)
Image: Meridian is presenting its innovative solutions in molecular and immunoassay reagents at MEDICA 2024 (Photo courtesy of Meridian)

Meridian Bioscience (Cincinnati, OH, USA) is presenting its innovative solutions in molecular and immunoassay reagents that are designed to simplify assay design, eliminate cold-chain logistics, and improve sustainability. The company is also highlighting its large portfolio of antigens, antibodies, blockers, molecular enzymes, nucleotides, and optimized mixes for qPCR, isothermal amplification, and NGS applications for the IVD industry.

Meridian’s glycerol-free, high-concentration molecular reagents, and services enable the development of ambient-temperature stable assays, eliminating the need for cold chain logistics and ensuring robust and seamless supply chains. This reduces energy consumption in transit and storage as well as minimizes packaging requirements, particularly the use of refrigerant, dry ice, and expanded polystyrene foam. Meridian’s extraction-free, low-temperature molecular solutions streamline workflows by eliminating the need for multiple reagent-based extraction steps and reducing the overall energy consumption required for high-temperature processes. Streamlined workflows with fewer steps result in faster turnaround times and increased throughput, reducing operational energy and resource use. Additionally, Meridian’s animal-free recombinant alternatives for immunoassays (blockers, antibodies, and antigens) can offer greater versatility and reproducibility over animal immunization, ensuring continuity of supply while alleviating ethical concerns.

Meridian is highlighting its recently launched glycerol-free NGS enzymes, further establishing the company as a leader in developing innovative, eco-conscious, and cost-effective components for diagnostic assay developers. Visitors to Meridian’s booth at the show can also learn about the company’s introduction of the market’s first innovative lyophilized Next-Generation Sequencing (NGS) library preparation kit. This revolutionary lyophilized NGS library preparation kit, designed initially for sequencing by synthesis (SBS) protocols, marks a breakthrough in stabilizing the library preparation process at room temperature. The pioneering kit can be transported and stored at ambient temperature and contains ready-to-use lyophilized reactions to simplify the end-repair, A-tailing, ligation, and library amplification steps of most sequencing protocols. By eliminating the requirement for cold-chain shipping and storage, Meridian’s innovative kit not only simplifies logistical and environmental challenges but also significantly reduces carbon emissions and operational costs, thereby streamlining the entire NGS workflow.

Related Links:
Meridian Bioscience

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.